SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Spectrum Pharmaceuticals, Inc. To Contac...
September 21 2016 - 4:53PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities law
firm, reminds investors in Spectrum Pharmaceuticals, Inc.
(“Spectrum” or the “Company”) (NasdaqGS:SPPI) of the November 21,
2016 deadline to seek the role of lead plaintiff in a federal
securities class action lawsuit filed against the Company and
certain officers.
The lawsuit was filed on September 21, 2016 in the U.S. District
Court for the Central District of California on behalf of all those
who purchased Spectrum securities between December 16, 2015 and
September 16, 2016 ( “Class Period”). The case is Ayeni v. Spectrum
Pharmaceuticals, Inc. et al, No. 2:16-cv-07074.
The lawsuit focuses on whether the Company and executives
violated federal securities laws by failing to disclose that the
FDA advised defendants not to submit a New Drug Application for
Qapzola, questioning the clinical and statistical validity of the
611 and 612 studies’ results.
Request more information now by clicking here:
www.faruqilaw.com/SPPI . There is no cost or obligation
to you.
Take Action
If you invested in Spectrum securities during the Class Period
and would like to discuss your legal rights, visit
www.faruqilaw.com/SPPI. You can also contact us by calling Richard
Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending
an e-mail to rgonnello@faruqilaw.com.
The court-appointed lead plaintiff is the investor with the
largest financial interest in the relief sought by the class that
is adequate and typical of class members who directs and oversees
the litigation on behalf of the putative class. Any member of the
putative class may move the Court to serve as lead plaintiff
through counsel of their choice, or may choose to do nothing and
remain an absent class member. Your ability to share in any
recovery is not affected by the decision of whether or not to serve
as lead plaintiff.
Attorney Advertising. The law firm responsible for this
advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with
respect to any future matter. We welcome the opportunity to discuss
your case. All communications will be treated in a confidential
manner.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160921006543/en/
FARUQI & FARUQI, LLP685 Third Avenue, 26th FloorNew York, NY
10017Attn: Richard Gonnello, Esq.rgonnello@faruqilaw.comTelephone:
877-247-4292 or 212-983-9330
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Spectrum Pharmaceuticals (NASDAQ:SPPI)
Historical Stock Chart
From Apr 2023 to Apr 2024